Oxygen Biotherapeutics, Inc. To Present at OneMedForum 2010
11 Januar 2010 - 2:30PM
PR Newswire (US)
DURHAM, N.C., Jan. 11 /PRNewswire-FirstCall/ -- Oxygen
Biotherapeutics, Inc. (OTC:OXBT) (BULLETIN BOARD: OXBT) announced
today that company chairman and CEO Chris Stern will present at the
OneMedForum 2010 investor conference in San Francisco on Wednesday,
Jan. 13, 2010. The presentation, limited by conference organizers
to 10 minutes per company, will be at 9:00 a.m. pacific time and
will be webcast live. A link to the webcast will be available the
day of the presentation at the following url:
http://www.onemedplace.com/onemedforum/index.php?option=com_content&task=view&
id=96. About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics,
Inc. is dedicated to commercializing innovative pharmaceuticals and
medical devices in the field of oxygen therapeutics and Defense
Medicine(TM). The company has developed a perfluorocarbon (PFC)
therapeutic oxygen carrier and liquid ventilation product
(Oxycyte(TM)) and has out-licensed an implantable glucose sensor.
These products are based upon core technologies that include
biomedical applications for PFCs as well as medical and industrial
applications for biosensors. Each of the product candidates is
designed with advantages over currently marketed products in major
markets including traumatic brain injury, sickle cell crisis,
trauma, wound care, decompression sickness, acute respiratory
distress syndrome, stroke, myocardial infarction, surgery, diabetes
wounds and ulcers, and cosmetic applications which are being
marketed under the Dermacyte name. More information is available at
http://www.oxybiomed.com/. DATASOURCE: Oxygen Biotherapeutics, Inc.
CONTACT: Abe Wischnia of Abe Wischnia & Associates,
+1-619-795-2345, for Oxygen Biotherapeutics, Inc. Web Site:
http://www.oxybiomed.com/
Copyright